Results 41 to 50 of about 4,591,759 (294)

Personalized Selumetinib Dosing in Pediatric Neurofibromatosis Type 1: Insights From a Pilot Therapeutic Drug Monitoring Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Objective To evaluate selumetinib exposure using therapeutic drug monitoring (TDM) in pediatric patients with neurofibromatosis type 1 (NF1) and plexiform neurofibromas (PN), assess interpatient pharmacokinetic variability, and explore the relationship between drug exposure, clinical response, and adverse effects.
Janka Kovács   +8 more
wiley   +1 more source

LIFE Monza: comparison between ante and post-operam noise and air quality monitoring activities in a Noise Low Emission Zone

open access: yesNoise Mapping, 2020
LIFE MONZA project (Methodologies fOr Noise low emission Zones introduction And management) aims at defining an easy-replicable method for the identification and management of the Noise Low Emission Zones (Noise LEZ), urban areas subject to traffic ...
Silvaggio Rosalba   +18 more
doaj   +1 more source

Sound complexity as a strategy for livable and sustainable cities: The case of an urban waterfront

open access: yesNoise Mapping, 2023
Public spaces underwent a notable shift in their acoustic profile during the societal restrictions resulting from the COVID-19 pandemic. A silver lining emerged from this global crisis, with noticeable improvements in public acoustic environments due to ...
Tsaligopoulos Aggelos   +6 more
doaj   +1 more source

Stable Maps and Schwartz Maps [PDF]

open access: yesTransactions of the American Mathematical Society, 1970
Mathematics Technical ...
openaire   +2 more sources

Outcome Mapping [PDF]

open access: yes, 2008
{Excerpt} Development is about people—it is about how they relate to one another and their environment, and how they learn in doing so. Outcome mapping puts people and learning first and accepts unexpected change as a source of innovation.
Serrat, Olivier
core   +1 more source

Sirolimus for Extracranial Arteriovenous Malformations: A Scoping Review of the Evidence in Syndromic and Non‐Syndromic Cases

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Arteriovenous malformations (AVMs) are rare, high‐flow, vascular anomalies that can occur either sporadically or as part of a genetic syndrome. AVMs can progress with serious morbidity and even mortality if left unchecked. Sirolimus is an mTOR inhibitor that is effective in low‐flow vascular malformations; however, its role in AVMs is unclear.
Will Swansson   +3 more
wiley   +1 more source

Arc mapping [PDF]

open access: yes, 2010
Establishing a compartment fire's area of origin when it has been burning at post-flashover conditions is a difficult process. Burn patterns traditionally used by fire investigators following post-flashover fires can be erroneous.
Carey, Nicholas, NicDaeid, N.
core   +1 more source

Intravitreal GD2‐Specific Chimeric Antigen Receptor T‐Cell Therapy for Refractory Retinoblastoma

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Effective treatments for advanced, treatment‐resistant retinoblastoma (RB) remain limited. GD2‐specific chimeric antigen receptor (CAR) T cells show potent antitumor activity with minimal toxicity but have not previously been evaluated in RB.
Subongkoch Subhadhirasakul   +13 more
wiley   +1 more source

Analytic derivation of the map of null rays passing near a naked singularity [PDF]

open access: yes, 2000
Recently the energy emission from a naked singularity forming in spherical dust collapse has been investigated. This radiation is due to the particle creation in a curved spacetime.
L. H. Ford   +9 more
core   +2 more sources

Outcomes of Live Virus Vaccination in Patients With Vascular Anomalies Being Treated With Sirolimus

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Live vaccination in patients with vascular anomalies (VA) receiving sirolimus remains controversial due to immunosuppressive effects and theoretical risks. Procedure This single‐center retrospective study included patients with VA less than 4 years old at the start of sirolimus therapy who were incompletely vaccinated.
Svatava Merkle   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy